News & Events

2012 Press Releases

Eidogen-Sertanty Releases Mobile Reagents on Windows 8 Devices based on Intel Architecture

San Diego, CA (May 29, 2013) - Eidogen-Sertanty, Inc. announces the release of a Windows 8 version of its popular Mobile Reagents app for devices based on Intel® Architecture, an app which provides access to over 17 million chemical products offered by more than 58 suppliers. Over 12,000 users actively use Mobile Reagents worldwide running on iOS and Android mobile devices. With this release of Mobile Reagents on Windows 8, Eidogen expects to more than double the Mobile Reagents user community.

Working with Intel, Eidogen developed and optimized Mobile Reagents for Windows 8 devices based on Intel Architecture - enhancing the landscape of touch-enabled software already popular with the scientific community. Unlike iOS and Android, Windows 8 has the distinct advantage of running both on touch-enabled mobile devices and the massive install-base of laptops and desktops.



Visit App Store




For more information, please contact:

Steve Muskal
760-651-2885
pr@eidogen-sertanty.com

About Eidogen-Sertanty, Inc.

Eidogen-Sertanty is a privately held company that is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit www.eidogen-sertanty.com.

About Intel

Intel (NASDAQ: INTC) is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world's computing devices. Additional information about Intel is available at newsroom.intel.com and blogs.intel.com

Intel is a trademark of Intel Corporation in the United States and other countries.